Shailendra Singh

Founder & CEO - Cellomatics BioSciences Ltd.

[Cellomatics Biosci @CBioscien]

We are thrilled to announce that Cellomatics CEO and Founder Shailendra Singh has been shortlisted for the East Midlands Boardroom Awards 2026, within the category of Scale-up Entrepreneur of the Year.

Read more about the shortlist here https://t.co/p4AskcO9Lx

[The Supply Chain Report @SupplyChainRep]

We’re thrilled to welcome Cellomatics Biosciences (@CBioscien) to the 2025 Go Global Awards! 🌍 Your participation highlights excellence, innovation, and global collaboration. Thank you for joining this platform celebrating leadership and success! #GoGlobalAwards2025

[Go Global Awards @GoGlobalAwards]

We’re thrilled to welcome Cellomatics Biosciences (@CBioscien) to the 2025 Go Global Awards! 🌍 Your participation highlights excellence, innovation, and global collaboration. Thank you for joining this platform celebrating leadership and success! #GoGlobalAwards2025

[DerbyUniBis @DerbyUniBis]

🔬 Exciting growth for @CBioscien 🚀

With support from @DerbyUni’s Invest to Grow, @CBioscien has expanded its lab capabilities - boosting productivity, creating jobs & driving biomedical innovation in oncology, immunology & more. 🚀

Find out more👉 https://t.co/PPukVNBoWP

[Shailendra Singh @ShailShanSingh]

Excited to share my article on how organoid and 3D models are redefining drug testing @CBioscien
https://t.co/8DeWtKRcuP

#Organoids #DrugDiscovery #PreclinicalResearch #HumanRelevantModels
#3DCellCulture

[Shailendra Singh @ShailShanSingh]

Excited to share my article on how organoid and 3D models are redefining drug testing @CBioscien
https://t.co/8DeWtKRcuP

#Organoids #DrugDiscovery #PreclinicalResearch #HumanRelevantModels
#3DCellCulture

[Cellomatics Biosci @CBioscien]

Are you interested in how your compound affect the cell surface markers or cytokine release of different immune cells?

For more information please visit: https://t.co/whH64NtCqK

[Cellomatics Biosci @CBioscien]

In our most recent blog we discuss the latest innovations in skin research, the rise in in vitro alternatives and how the models created at Cellomatics are helping to aid therapeutic discovery.

Visit our website to read the piece: https://t.co/5hLRkp5ttE

[Cellomatics Biosci @CBioscien]

August is psoriasis awareness month, a month dedicated to raising awareness about psoriasis, a chronic autoimmune condition affecting the skin.

Visit our website to learn more about the research we are doing into psoriasis at Cellomatics here: https://t.co/DB1NVjN8Q7

[Cellomatics Biosci @CBioscien]

Our Parkinson’s disease neuroinflammation model uses differentiated SH-SY5Y neurons treated with 6-OHDA, enabling high-throughput, reproducible insights with multiple readout options including ELISA, qPCR, and imaging.

Find out more: https://t.co/1fIgW9ahWz

[Cellomatics Biosci @CBioscien]

September is Blood Cancer Awareness Month and 15 September marks World Lymphoma Awareness Day.

Learn more about blood cancer and the various in vitro assays we have developed at Cellomatics to support drug discovery projects against diseases like these: https://t.co/2MfeqrAnOZ

[Cellomatics Biosci @CBioscien]

Our latest Science Communication piece is live🧑‍🔬

Visit out website for an in depth look at the molecular capabilities we have at Cellomatics and how you may be able to utilise them for your projects: https://t.co/nKw52O21se

[Cellomatics Biosci @CBioscien]

Our T-cell assays provide powerful insights into immune function—from polarisation and proliferation to killing activity—using flexible readouts including cell counts, cytokine release, multiplex analysis, and imaging.

Learn more: https://t.co/WvxU2z1trW

[Cellomatics Biosci @CBioscien]

Cellomatics offer customisable, high-throughput Caco-2 IBD models that can deliver physiologically relevant insights into Crohn’s and colitis, with flexible readouts including cytokine release, gene expression, and barrier integrity.

Find out more: https://t.co/GdxdZZqBy0

[Cellomatics Biosci @CBioscien]

We're thrilled to announce that Cellomatics has been nominated for the prestigious Go Global Awards 2025, which will be held in November 18–19, at One Great George Street, Westminster, London.

Find out more here: https://t.co/rj2UWhNHhX

[Cellomatics Biosci @CBioscien]

Cellomatics has been named as a finalist for the prestigious Bioscience Innovator of the Year award at the Go Global Awards 2025!

Visit our website to find out more: https://t.co/rj2UWhNHhX

[Cellomatics Biosci @CBioscien]

Our NETosis Assay delivers high-throughput, customisable analysis using freshly isolated immune cells from healthy and diseased donors. With flexible readouts you gain powerful insights into immune mechanisms and drug effects.

Learn more here: https://t.co/tHN3blgSYz

[Cellomatics Biosci @CBioscien]

Here at Cellomatics we have the means to recruit donors to our facility and collect blood onsite for fresh immune cell isolation thereby improving the outcome of your immunology projects.

For more information visit: https://t.co/Upriz7sVcm

[Cellomatics Biosci @CBioscien]

Are you interested in testing the efficacy of your compounds for the treatment of psoriasis? At Cellomatics we have a validated complex co-culture model that mimics the in vivo environment and encompasses immune cell involvement in psoriasis progression: https://t.co/qmP2zWzzOz